Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Udagawa

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 1, 1994
[Clinical significance of galactosyltransferase associated with tumor (GAT), a new tumor marker for ovarian cancer--with special reference to the discrimination between ovarian cancer and endometriosis]S Nozawa, Y Udagawa, K Ito, et al.
Japanese Journal of Cancer Research : Gann|July 1, 1991
A new CA125-like antigen (CA602) recognized by two monoclonal antibodies against a newly established ovarian clear cell carcinoma cell line (RMG-II)S Nozawa, M Yajima, H Sasaki, et al.
Human Cell|March 1, 1990
[Biological properties of two newly established cell lines (RMUG-S, RMUG-L) from a human ovarian mucinous cystadenocarcinoma]M Sakayori, S Nozawa, Y Udagawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 2, 2001
[Dose finding study of paclitaxel and carboplatin for ovarian cancer (JKTB)]M Yasuda, E Kimura, K Ochiai, et al.
Placenta|October 22, 2013
Contribution of fetal ANXA5 gene promoter polymorphisms to the onset of pre-eclampsiaS Ota, H Miyamura, H Nishizawa, et al.
Clinical & Experimental Metastasis|April 22, 1999
A patient-like orthotopic implantation nude mouse model of highly metastatic human ovarian cancerK Kiguchi, T Kubota, D Aoki, et al.
Annals of the New York Academy of Sciences|February 10, 2000
Intracellular signaling of the TGF-beta superfamily by Smad proteinsM Kawabata, T Imamura, H Inoue, et al.
Gynecologic Oncology|September 30, 1999
Cervical adenocarcinoma, a novel combination chemotherapy with mitomycin C, etoposide, and cisplatin for advanced or recurrent diseaseN Umesaki, R Izumi, H Fushiki, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 1, 1994
[Clinical significance of galactosyltransferase associated with tumor (GAT), a new tumor marker for ovarian cancer--with special reference to the discrimination between ovarian cancer and endometriosis]S Nozawa, Y Udagawa, K Ito, et al.
Japanese Journal of Cancer Research : Gann|July 1, 1991
A new CA125-like antigen (CA602) recognized by two monoclonal antibodies against a newly established ovarian clear cell carcinoma cell line (RMG-II)S Nozawa, M Yajima, H Sasaki, et al.
Human Cell|March 1, 1990
[Biological properties of two newly established cell lines (RMUG-S, RMUG-L) from a human ovarian mucinous cystadenocarcinoma]M Sakayori, S Nozawa, Y Udagawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 2, 2001
[Dose finding study of paclitaxel and carboplatin for ovarian cancer (JKTB)]M Yasuda, E Kimura, K Ochiai, et al.
Placenta|October 22, 2013
Contribution of fetal ANXA5 gene promoter polymorphisms to the onset of pre-eclampsiaS Ota, H Miyamura, H Nishizawa, et al.
Clinical & Experimental Metastasis|April 22, 1999
A patient-like orthotopic implantation nude mouse model of highly metastatic human ovarian cancerK Kiguchi, T Kubota, D Aoki, et al.
Annals of the New York Academy of Sciences|February 10, 2000
Intracellular signaling of the TGF-beta superfamily by Smad proteinsM Kawabata, T Imamura, H Inoue, et al.
Gynecologic Oncology|September 30, 1999
Cervical adenocarcinoma, a novel combination chemotherapy with mitomycin C, etoposide, and cisplatin for advanced or recurrent diseaseN Umesaki, R Izumi, H Fushiki, et al.
Pageof 8